Aptar Pharma will introduce its new DF30Plus metering valve at this year’s Drug Delivery to the Lungs conference, the company said. The DF30Plus is based on the company’s widely-used DF30 metering valve and features a cyclic olefin copolymer (COC) neck gasket developed at Aptar’s in-house Elastomer Center, which offers ultra-low extractable levels and is compatible with most pMDI formulations and all filling technologies.
Aptar Pharma Associate Director, Business Development, Chris Baron commented, “Thanks to the introduction of our novel COCe within our DF30 Valve Technology Platform, Aptar Pharma is able to offer a series of key advantages to meet the evolving needs of our customers, including improved compatibility with both EtOH containing and dry drug formulations, superior cleanliness and improved leakage barrier characteristics which result in a more robust and less crimp sensitive manufacturing process.”
